Tess Egginton

Fulcrum Therapeutics, a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, has entered...

Chiesi Group, a research-oriented international biopharmaceutical group, has signed a memorandum of understanding with Karolinska Institutet, a medical university. The agreement solidifies a commitment between the...

Sanofi has entered into a co-exclusive licensing agreement with Novavax. The terms of the agreement include: a co-exclusive license to co-commercialize Novavax’s current stand-alone adjuvanted...